Neurological Institute

Friday, February 02, 2018

University Hospitals launches new vision statement: ‘Advancing the Science of Health and the Art of Compassion’

CLEVELAND – University Hospitals is launching a new vision statement to guide the future success and aspirations of the health system, its 18 hospitals, 26,000 employees and 1.3 million patients annually served.
 
The statement -- Advancing the Science of Health and the Art of Compassion -- defines UH as a nationally leading academic medical research center and health system grounded in pioneering research, new technologies and compassionate and personalized patient care.
 
As part of the vision launch, UH also will kick off an advertising campaign with two commercials airing during the Super Bowl on Feb. 4.  The commercials are part of a series of spots featuring real patients and their caregivers sharing their UH experiences. 
 
Following their initial showings, the commercials will be shown on TV stations in Northeast Ohio, in conjunction with ads on radio, in newspapers and digital platforms.






Tuesday, October 10, 2017

Nature Medicine study: Areas of glioblastoma tumors correlate with separate subtypes of glioma stem cells, respond better to combination treatment

CLEVELAND – A new study published in the Oct. 9 issue of the journal Nature Medicine demonstrates, for the first time, that glioblastoma (GBM), the most common and most lethal brain tumor, is driven by two distinct subsets of cancer stem cells.  Moreover, each subtype of glioma stem cells is driven by distinct transcriptional programs for growth and treatment resistance, and these different cell populations correspond to well-known morphological differences within the GBM itself. 
 
More importantly, the researchers found that while chemotherapeutic agents targeting each subtype achieve modest efficacy alone, they are synergistic when combined as demonstrated in a mouse model.
 
Senior co-author of the study, Andrew Sloan, MD, Medical Director, Brain Tumor and Neuro-Oncology Center at University Hospitals Cleveland Medical Center observed that GBMs typically have two radiologically distinct regions on MRI:  The enhancing mass and the necrotic core.  


Sunday, September 10, 2017

CWRU & University Hospitals Physician-Researcher Martha Sajatovic, MD, receives international brain health grant, joins team in new diabetes research project

CLEVELAND – Martha Sajatovic, MD, Professor of Psychiatry and of Neurology at Case Western Reserve University School of Medicine, Willard Brown Chair in Neurological Outcomes Research and Director of the Neurological and Behavioral Outcomes Research Center at University Hospitals Cleveland Medical Center, is the recent recipient of two major research grants.

As principal investigator (PI), Sajatovic will lead a National Institutes of Health (NIH) Fogarty International Center for Health grant in Tanzania with colleagues at Muhimbili University of Health and Allied Services to reduce the burden of chronic psychotic disorders using a customized adherence enhancement program combined with injectable, long-acting antipsychotic medication. The combined treatment approach was developed by Sajatovic’s team in Cleveland. Cleveland collaborators include Jennifer Levin, PhD, of UH and CWRU, and Carol Blixen, PhD, RN of CWRU. This grant is funded to CWRU for two years in the amount of $275,000.

 



  • News Media Access



  • Register
  • Forgot My Password
  • Search:




    Advanced Search

  • Subscribe To Our Latest News

    Subscribe to University Hospitals' RSS Feeds or Email Alerts to get our latest news.

    University Hospitals RSS Feed  University Hospitals Email Alerts
  • Twitter

    Must select a Twitter Account for Rail Gadget in Twitter Tool.

You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.